Clinical Trials

Clinical Trials

To fulfill Dr. Miller’s passion for clinical research, Advanced Neurology of Colorado has a research counterpart, Advanced Neurosciences Research, LLC.  Currently, the research team participates in over 15 clinical trials, including those listed below. Following are the clinical trials that we are currently enrolling participants. For more information, please visit http://www.clinicaltrials.gov

Multiple Sclerosis Trials

AFFINITY215MS202

A multi-center, randomized, double-blind, placebo-controlled study in subjects with relapsing multiple sclerosis to evaluate the efficacy and safety of BIIB033 as an add-on therapy to anti-inflammatory disease-modifying therapies

COMB157G2302

A randomized, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of ofatumumab versus teriflunomide in patients with relapsing multiple sclerosis

MNK14130050

A prospective observational registry of H.P. Acthar® Gel for the treatment of multiple sclerosis relapse

MNK14274069

A multicenter, randomized, double blind, placebo controlled parallel group, pilot study to assess the efficacy and safety of H.P. Acthar® Gel in subjects with relapsing-remitting multiple sclerosis

COMING SOON:

All of our trials are currently enrolling, please continue to check back for upcoming trials


Migraine Trials

Please visit migrainepainresearch.com to see if you prequalify for the studies below.

UBR-MD-02                                                                                                                          

A multicenter, randomized, double- blind, placebo-controlled single attack study to evaluate the efficacy, safety, and tolerability or oral ubrogepant in the acute treatment of migraine

CGP-MD-01

A phase 2/3, multicenter, randomized, double-blind, placebo controlled, parallel- group study to evaluate the efficacy, safety, and tolerability of multiple dosing regimens of oral AGN-241689 in episodic migraine prevention

COMING SOON:

All of our trials are currently enrolling, please continue to check back for upcoming trials


Dementia Trials

IDEAS

The IDEAS Study is an observational, open-label, longitudinal cohort study designed to assess the impact of amyloid PET on patient-oriented outcomes in Medicare beneficiaries with mild cognitive impairment (MCI) or dementia of uncertain etiology.

COMING SOON:

All of our trials are currently enrolling, please continue to check back for upcoming trials